From: Occult HBV infection among Egyptian hepatocellular carcinoma patients
Variables | No.(%) |
---|---|
HCV-RNA | 10/25 (40%) |
High AFP | 15/25(60%) |
Liver cirrhosis | 18/25(72%) |
Tumor Grade I | 4/25(16%) |
Tumor Grade II | 13/25(52%) |
Tumor Grade III | 8/25(32%) |
X-gene and HBcIgG +ve | 12/25(48%) |
S-gene and HBcIgG +ve | 16/25(64%) |
C-gene and HBcIgG +ve | 20/25(80%) |
HBV genotype A | 1/25 (4%) |
HBV genotype B | 6/25 (24%) |
HBV genotype C | 2/25 (8%) |
HBV genotype D | 8/25 (32%) |
HBV mixed genotype | 5/25 (20%) |